How Much Does Tirzepatide Cost? (2026 Guide)

Tirzepatide Cost at a Glance

Tirzepatide is sold under two brand names — Mounjaro® (type 2 diabetes) and Zepbound® (weight management) — and is also available in compounded form through licensed telehealth providers. What you pay depends heavily on which route you take and whether you have insurance coverage.

• Brand-name Zepbound® (no insurance): approximately $1,050-$1,400 per month
• Brand-name Mounjaro® (no insurance): approximately $1,000-$1,300 per month
• Compounded tirzepatide (telehealth): typically $200-$400 per month, with introductory offers as low as $149 for your first month at AvataCore

See AvataCore pricing → for current plans and dosing.

Why Is Brand-Name Tirzepatide So Expensive?

Brand-name GLP-1 medications carry high list prices set by their manufacturers. Without insurance coverage — which the majority of Americans lack for weight-loss indications — patients face the full retail cost. Even with insurance, prior authorization requirements, step therapy, and high co-pays create substantial barriers.

Does Insurance Cover Tirzepatide?

For Diabetes (Mounjaro)

Coverage for tirzepatide as a diabetes treatment is relatively common across commercial and government plans, though prior authorization is usually required.

For Weight Loss (Zepbound)

Coverage is far less consistent. Many commercial plans exclude weight-loss medications entirely. Medicare does not cover medications prescribed solely for weight loss, though coverage has expanded for certain cardiovascular indications. Medicaid coverage varies by state.

HSA and FSA: Lower Your Effective Cost

If you have a Health Savings Account (HSA) or Flexible Spending Account (FSA), you can pay for prescribed tirzepatide and telehealth visits with pre-tax dollars. For someone in the 22% federal tax bracket, a $300/month program effectively costs about $234/month after the tax advantage. Eligible expenses include the prescription, consultation fees, and provider-ordered lab work.

How Compounded Tirzepatide Saves Money

Compounded tirzepatide through a licensed telehealth provider typically costs 15-30% of the brand-name price. Over a year, that is the difference between roughly $12,600-$16,800 (brand-name) and $2,400-$4,800 (compounded) — potential savings of $10,000 or more annually. Compounded tirzepatide is not FDA-approved and differs from brand-name Zepbound® and Mounjaro®. Learn more in our compounded tirzepatide guide.

Manufacturer Savings Programs

Eli Lilly offers co-pay savings cards for commercially insured patients, which can lower out-of-pocket costs for those whose plans already cover the medication. These programs typically exclude Medicare, Medicaid, and uninsured patients.

The Bottom Line

For most people paying out of pocket, compounded tirzepatide through a licensed provider is the most accessible way to start treatment. AvataCore offers transparent pricing with no hidden fees and introductory offers for new patients.